Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

118.55
+1.951.67%
Post-market: 118.41-0.1383-0.12%19:30 EDT
Volume:7K
Turnover:797.37K
Market Cap:103.14M
PE:- -
High:118.55
Open:115.47
Low:115.47
Close:116.60
52wk High:126.40
52wk Low:55.34
Shares:870.00K
Float Shares:870.00K
Volume Ratio:0.69
T/O Rate:0.78%
Dividend:0.33
Dividend Rate:0.27%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
3 hours ago

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Reuters
·
5 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
9 hours ago

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
9 hours ago

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
10 hours ago

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Yesterday

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Yesterday

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Yesterday

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS
·
Yesterday

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Yesterday

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live
·
Yesterday

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Yesterday

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS
·
Yesterday

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Yesterday

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Yesterday

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Yesterday

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Yesterday

Political and General News Events from August 31

Reuters
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31